仅用于工业应用或科学研究，不可用于人类或动物的临床诊断或治疗，非药用. Gavilimomab （ABX-CBL） is an IgM murine monoclonal antibody that recognizes CD147 on the cell surface and initiates cell killing through complement-mediated lysis. Gavilimomab can be used for the research of graft-versus-host disease （GVHD）